Lung Cancer and Respiratory Diseases



The Lung Cancer and Respiratory Diseases Unit investigates the molecular mechanisms altered in respiratory diseases. Its interest is to evaluate the clinical utility of IGFs (Insulin-like Growth Factors) proteins, either as biomarkers or molecular targets of these pathologies. He collaborates with clinicians of the Hospital de Logroño and with multiple national and international groups. With the Chemist MATMO Group of the University of La Rioja, they explore the theranostic use of new compounds and photoactive nanomaterials.